OOIR: Observatory of International Research

Papers

(The TQCC of Circulation-Cardiovascular Quality and Outcomes is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China	506
Race, Racism, and Cardiovascular Health: Applying a Social Determinants of Health Framework to Racial/Ethnic Disparities in Cardiovascular Disease	105
Recommendations for Reporting Machine Learning Analyses in Clinical Research	105
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to	70
Importance of Housing and Cardiovascular Health and Well-Being: A Scientific Statement From the American Heart Association	69
The Groundwater of Racial and Ethnic Disparities Research	65
Rapid Diet Assessment Screening Tools for Cardiovascular Disease Risk Reduction Across Healthcare Settings: A Scientific Statement From the American Heart Association	58
Randomized Pragmatic Trial of Stroke Transitional Care	52
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care Patients	50
Understanding How Cardiac Arrest Complicates the Analysis of Clinical Trials of Cardiogenic Shock	46
Obesity Prevalence and Risks Among Chinese Adults: Findings From the China PEACE Million Persons Project, 2014–2018	45
Survival in Patients With Suspected Myocardial Infarction With Nonobstructive Coronary Arteries: A Comprehensive Systematic Review and Meta-Analysis From the MINOCA Global Collaboration	44
Cardiovascular and Cerebrovascular Disease Mortality in Asian American Subgroups	43
Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic	42
Changes in the United States Adult Heart Allocation Policy	42
American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines	41
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure	39
Harnessing Mobile Health Technology for Secondary Cardiovascular Disease Prevention in Older Adults: A Scientific Statement From the American Heart Association	38
Utilization and Availability of Advanced Imaging in Patients With Acute Ischemic Stroke	37
Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis	35
Code Blue During the COVID-19 Pandemic	34
Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic Analysis	34
Working Agenda for Black Mothers	34
Contemporary Trends in Hospital Admissions and Outcomes in Patients With Critical Limb Ischemia	33
Use of Mobile Health Applications in Low-Income Populations	33

Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association	33
Advancing Value-Based Models for Heart Failure	32
External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature	32
Digital Health Intervention in Acute Myocardial Infarction	32
Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease Among Medicare Beneficiaries Between 2017 and 2018: Participation Rates and Outcomes	31
Cardiovascular Health Score and Lifetime Risk of Cardiovascular Disease	30
Impact of COVID-19 Pandemic on Critical Care Transfers for ST-Segment–Elevation Myocardial Infarction, Stroke, and Aortic Emergencies	29
Million Hearts Cardiac Rehabilitation Think Tank: Accelerating New Care Models	29
Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases	27
Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease	27
Social Determinants of Health Improve Predictive Accuracy of Clinical Risk Models for Cardiovascular Hospitalization, Annual Cost, and Death	27
Comparative Efficacy of 5 Exercise Types on Cardiometabolic Health in Overweight and Obese Adults: A Systematic Review and Network Meta-Analysis of 81 Randomized Controlled Trials	27
Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States	26
Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018	26
Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome	26
Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association	25
Performance Metrics for the Comparative Analysis of Clinical Risk Prediction Models Employing Machine Learning	24
ABCs of Stroke Prevention	24
Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease	23
Cardio-Renal-Metabolic Care Models	23
Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models	22
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-Analysis	22
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation	21
Role of Data Registries in the Time of COVID-19	20
Microrandomized Trial Design for Evaluating Just-in-Time Adaptive Interventions Through Mobile Health Technologies for Cardiovascular Disease	20
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy	20
Sudden Cardiac Death in the Young	20
2021 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19	20
Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018	19
Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation	19
Relationship of Preeclampsia With Maternal Place of Birth and Duration of Residence Among Non-Hispanic Black Women in the United States	19
Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study	19
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study	19
Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation	19
Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes	19
2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing	18
Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States	18
Rural-Urban Differences in Mortality From Ischemic Heart Disease, Heart Failure, and Stroke in the United States	18
Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease	18
Streamlining and Reimagining Prior Authorization Under Value-Based Contracts: A Call to Action From the Value in Healthcare Initiative’s Prior Authorization Learning Collaborative	18
Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial	17
Transcatheter Aortic Valve Replacement in Low-Population Density Areas	17
Characteristics and Quality of National Cardiac Registries: A Systematic Review	17
Variation in Out-of-Hospital Cardiac Arrest Survival Across Emergency Medical Service Agencies	17
Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer	17
Impact of Produce Prescriptions on Diet, Food Security, and Cardiometabolic Health Outcomes: A Multisite Evaluation of 9 Produce Prescription Programs in the United States	16
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease	16
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial	16
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19	16
Determinants of Hospital Variation in Cardiac Rehabilitation Enrollment During Coronary Artery Disease Episodes of Care	16

Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System	16
Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction	16
Estimating the Effect of Reduced Attendance at Emergency Departments for Suspected Cardiac Conditions on Cardiac Mortality During the COVID-19 Pandemic	16
Higher Emergency Physician Chest Pain Hospitalization Rates Do Not Lead to Improved Patient Outcomes	15
Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction	15
Food Insecurity and Cardiovascular Mortality for Nonelderly Adults in the United States From 2011 to 2017	15
The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study	15
Text Message Medication Adherence Reminders Automated and Delivered at Scale Across Two Institutions: Testing the Nudge System: Pilot Study	15
2022 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Car	15
Integrated Care in Atrial Fibrillation	14
Navigating Healthcare Supply Shortages During the COVID-19 Pandemic	14
Practical Application of Patient-Reported Health Status Measures for Transcatheter Valve Therapies	14
Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults	14
Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement	14
ST-Segment–Elevation Myocardial Infarction Care and COVID-19	14
Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times	14
Ten-Year Trends in Patient Characteristics, Treatments, and Outcomes in Myocardial Infarction From National Cardiovascular Data Registry Chest Pain–MI Registry	14
Survival After In-Hospital Cardiac Arrest in Critically Ill Patients	14
Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes	14
Cardiovascular Disease Risk–Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network	14
Conflicting Perspectives on the Value of Neprilysin Inhibition in Heart Failure Revealed During Development of a Decision Aid Focusing on Patient Costs for Sacubitril/Valsartan	14
Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Dis	13
County-Level Social Vulnerability is Associated With In-Hospital Death and Major Adverse Cardiovascular Events in Patients Hospitalized With COVID-19: An Analysis of the American Heart Association COV	13
Sources of Hospital Variation in Postacute Care Spending After Cardiac Surgery	13
Show Me the Money	13
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction	13
Trends in Consumer Wearable Devices With Cardiac Sensors in a Primary Care Cohort	13
Hybrid Training in Acute Cardiovascular Care	13
Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018	12
Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials	12
Socioeconomic Status and Outcomes in Heart Failure With Reduced Ejection Fraction From Asia	12
Individual Psychosocial Resilience, Neighborhood Context, and Cardiovascular Health in Black Adults	12
Letter by Pilz et al Regarding Article, “Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China”	12
2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Associati	12
Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome	12
Mendelian Randomization in Cardiovascular Research	11
Effectiveness of Stroke Early Supported Discharge	11
2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Dat	11
Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort	11
Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area	11
Be Prepared	11
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER	11
Association Between Early Trauma and Ideal Cardiovascular Health Among Black Americans	11
Estimation of the Absolute Risk of Cardiovascular Disease and Other Events: Issues With the Use of Multiple Fine-Gray Subdistribution Hazard Models	11
Association of an Acute Myocardial Infarction Readmission-Reduction Program With Mortality and Readmission	11
Severe Maternal Morbidity and Long-Term Risk of Cardiovascular Hospitalization	11
Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011–2018	11
Role of Spirituality on the Association Between Depression and Quality of Life in Stroke Survivor–Care Partner Dyads	10
Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration	10
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events	10
Cardiac Rehabilitation and the COVID-19 Pandemic: Persistent Declines in Cardiac Rehabilitation Participation and Access Among US Medicare Beneficiaries	10
In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge	10
National Trends of Sex Disparity in the American College of Cardiology/American Heart Association Guideline Writing Committee Authors Over 15 Years	10
Why Fibrinolytic Therapy for ST-Segment–Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend	10
Appropriateness of Transcatheter Aortic Valve Replacement	10
Provider Care Team Segregation and Operative Mortality Following Coronary Artery Bypass Grafting	10
Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry	10
Patient Perspectives on the Completion and Use of Patient-Reported Outcome Surveys in Routine Clinical Care for Heart Failure	10
Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States	10
Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association	10
Longitudinal Spending on Endovascular and Open Abdominal Aortic Aneurysm Repair	9
Best Practices for Education and Training of Resuscitation Teams for In-Hospital Cardiac Arrest	9
Cause of Death Among Patients With Peripheral Artery Disease	9
Screening for Intracranial Aneurysms in Coarctation of the Aorta	9
Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction	9
Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial	9
Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial	9
Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke	9
Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment	9
Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults With Cardiovascular Disease	9
Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY	9
Trends of Coronary Artery Bypass Grafting Performance in a Cohort of Hospitals in China Between 2013 and 2018	8
Reimagining Evidence Generation for Heart Failure and the Role of Integrated Health Care Systems	8
Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures	8
The New Adult Heart Allocation Policy	8
Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke	8
Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects	8
Hospital and Operator Variation in Cardiac Rehabilitation Referral and Participation After Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortiu	8
Toward Dynamic Risk Prediction of Outcomes After Coronary Artery Bypass Graft: Improving Risk Prediction With Intraoperative Events Using Gradient Boosting	8
Risk Stratification of Patients Undergoing Percutaneous Repair of Mitral and Tricuspid Valves Using a Multidimensional Geriatric Assessment	8

Joint Modeling of Longitudinal Markers and Time-to-Event Outcomes: An Application and Tutorial in Patients After Surgical Repair of Transposition of the Great Arteries	8
Contributions of Structural Racism to the Food Environment: A Photovoice Study of Black Residents With Hypertension in Baltimore, MD	7
Interim Guidance for Emergency Medical Services Management of Out-of-Hospital Cardiac Arrest During the COVID-19 Pandemic	7
Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?	7
Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries	7
Changes in Home Blood Pressure Monitored Among Elderly Patients With Hypertension During the COVID-19 Outbreak: A Longitudinal Study in China Leveraging a Smartphone-Based Application	7
Personalized, Electronic Health Record–Integrated Decision Aid for Stroke Prevention in Atrial Fibrillation: A Small Cluster Randomized Trial and Qualitative Analysis of Efficacy and Acceptability	7
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019	7
Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment	7
Examining Neighborhood Socioeconomic Status as a Mediator of Racial/Ethnic Disparities in Hypertension Control Across Two San Francisco Health Systems	7
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment–Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 Project	7
Rationale and Design of the SAFE-PAD Study	7
Competitive Sports, the Coronavirus Disease 2019 Pandemic, and Big Ten Athletics	7
Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015	7
Coronary Artery Bypass Surgery in Patients With COVID-19	7
Generalizability of DAPA-CKD to the United States	7
Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association	7
Reflections on the Values of Community-Based Participatory Research in Supporting Mobile Health Technology Use	7
Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia: A Quality Improvement Study	7
Progression of Preclinical Heart Failure: A Description of Stage A and B Heart Failure in a Community Population	7
Systemizing the Evaluation of Acute Heart Failure in the Emergency Department	7
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended In	7
The Cardiovascular Quality Improvement and Care Innovation Consortium	7
Use of Artificial Intelligence Tools Across Different Clinical Settings	7
Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation	7
Statin Prescribing Patterns During In-Person and Telemedicine Visits Before and During the COVID-19 Pandemic	6
Improving Outcome Predictions for Patients Receiving Mechanical Circulatory Support by Optimizing Imputation of Missing Values	6
Association of Cardiac Care Regionalization With Access, Treatment, and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction	6
Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study	6
Cardiometabolic Risk Factor Control During Times of Crises and Beyond	6
Social Determinants of Cardiovascular Health in an Era of Rising Social Disadvantage	6
Validity of International Classification of Diseases (ICD)-10 Diagnosis Codes for Identification of Acute Heart Failure Hospitalization and Heart Failure with Reduced Versus Preserved Ejection Fractio	6
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial	6
Practice Patterns and Outcomes Associated With Anticoagulation Use Following Sepsis Hospitalizations With New-Onset Atrial Fibrillation	6
Comparison of 0/3-Hour Rapid Rule-Out Strategies Using High-Sensitivity Cardiac Troponin I in a US Emergency Department	6
Financial Toxicity With Cardiovascular Disease Management	6
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study	6
Safer Stroke-Dx Instrument: Identifying Stroke Misdiagnosis in the Emergency Department	6
Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis	6
Sociodemographic Disparities in Outpatient Cardiology Telemedicine During the COVID-19 Pandemic	6
Perioperative Considerations for Pediatric Patients With Congenital Heart Disease Presenting for Noncardiac Procedures: A Scientific Statement From the American Heart Association	6
Examination of Sexual Identity Differences in the Prevalence of Hypertension and Antihypertensive Medication Use Among US Adults: Findings From the Behavioral Risk Factor Surveillance System	6
Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation	6
Association of State Medicaid Expansion Status With Hypertensive Disorders of Pregnancy in a Singleton First Live Birth	6
Exposure to Neighborhood-Level Racial Residential Segregation in Young Adulthood to Midlife and Incident Subclinical Atherosclerosis in Black Adults: The Coronary Artery Risk Development in Young Adul	6
Rates and Predictors of Patient Underreporting of Hospitalizations During Follow-Up After Acute Myocardial Infarction	6
Defibrillator Lead Survival	6
One-Year Outcomes and Factors Associated With Mortality Following Acute Myocardial Infarction in Northern Tanzania	5
Cardiovascular Risk Assessment Using Artificial Intelligence-Enabled Event Adjudication and Hematologic Predictors	5
Increasing Uptake of Depression Screening and Treatment Guidelines in Cardiac Patients: A Behavioral and Implementation Science Approach to Developing a Theory-Informed, Multilevel Implementation Stra	5
Determinants of Value in Coronary Artery Bypass Grafting	5
Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis	5
Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations	5
Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients	5
Cardiovascular Patient Perspectives on Value in the Healthcare Experience	5
Variation in Cardiac Rehabilitation Participation During Aortic Valve Replacement Episodes of Care	5
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force	5
Optimal Methods for Reducing Proxy-Introduced Bias on Patient-Reported Outcome Measurements for Group-Level Analyses	5
Cost Effectiveness of Interhospital Transfer for Mechanical Thrombectomy of Acute Large Vessel Occlusion Stroke	5
Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study	5
Echocardiographic and Electrocardiographic Abnormalities Among Elderly Adults With Cardiovascular Disease in Rural South Africa	5
American Heart Association Precision Medicine Platform Addresses Challenges in Data Sharing	5
Traditional Chinese Medicine in Treating Hypertension	5
Innovative Managed Care May Be Related to Improved Prognosis for Acute Myocardial Infarction Survivors	5
Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries	5
Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes	5
Advancing Value-Based Cardiovascular Care	5
Estimating Long-Term Health Utility Scores and Expenditures for Cardiovascular Disease From the Medical Expenditure Panel Survey	5
Improvement in Kansas City Cardiomyopathy Questionnaire Scores After a Self-Care Intervention in Patients With Acute Heart Failure Discharged From the Emergency Department	5
Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not “All About the Benjamins”	5
Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial	5
Does Dog Ownership Really Prolong Survival?	5
Impact of Medicare’s Bundled Payments Initiative on Patient Selection, Payments, and Outcomes for Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting	5
The Accreditation Council for Graduate Medical Education Mandates That You Attempt to Enhance Diversity in Your Cardiology Program	5
Response by Chan to Letter Regarding Article, “In-Hospital Cardiac Arrest Survival in the United States During and After the Initial Novel Coronavirus Disease 2019 Pandemic Surge”	5
Leveraging Remote Physiologic Monitoring in the COVID-19 Pandemic to Improve Care After Cardiovascular Hospitalizations	5
Changes in Emergency Department Arrival Times for Acute Myocardial Infarction During the COVID-19 Pandemic Suggest Delays in Care Seeking	5
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation	5
Influence of Hospital Characteristics on Hospital Transfer Destinations for Patients With Stroke	5
Contemporary Rates of Hospitalization for Heart Failure in Young and Middle-Aged Adults in a Diverse US State	5
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers	5
Understanding Baseline Physical Activity in Cardiac Rehabilitation Enrollees Using Mobile Health Technologies	5
Establishing Thresholds for Minimal Clinically Important Differences for the Peripheral Artery Disease Questionnaire	5
Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of	5
Patients With Acute Coronary Syndromes Admitted to Contemporary Cardiac Intensive Care Units: Insights From the CCCTN Registry	5
Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials	5
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization	5